Results 81 to 90 of about 10,061 (158)

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety

Medicines
Introduction: A direct head-to-head comparison between potent P2Y12 inhibitors: prasugrel versus ticagrelor is still lacking. Purpose: In this single-center study, we sought to address the efficacy and safety of these two third-generation antiplatelet ...
Fadel Bahouth, Boris Chutko, Haitham Sholy, Sabreen Hassanain, Gassan Zaid, Evgeny Radzishevsky, Ibrahem Fahmwai, Mahmod Hamoud, Nemer Samnia, Johad Khoury, Idit Dobrecky-Mery   +10 more
doaj   +1 more source

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Vascular Health and Risk Management
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Keiko ...
Kozaru M, Kambara H, Higuchi A, Kagatsume T, Hosohata K   +4 more
doaj  

2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping. [PDF]

J Am Heart Assoc
Cavallari LH, Lee CR, Beitelshees AL, Luzum JA, Stouffer GA, Ten Berg JM, van den Broek WWA, Pereira NL, Sibbing D, Angiolillo DJ.   +9 more
europepmc   +1 more source

Acquired Hemophilia A During Prasugrel Therapy After Recurrent Acute Coronary Syndrome. [PDF]

JACC Case Rep
Yao S, Fujisawa N, Otsuka K, Nagasaki J, Kawase T, Takahashi Y, Fukuda D.   +6 more
europepmc   +1 more source

Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study? [PDF]

J Atheroscler Thromb
Wakisaka Y, Ago T.
europepmc   +1 more source

Antithrombotic Therapy in Primary and Secondary Prevention of Coronary Artery Disease. [PDF]

J Clin Med
Di Leo G, Spagnolo M, Giacoppo D, Greco A, Capodanno D.   +4 more
europepmc   +1 more source

The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Mirhosseini SA, Mousavi A, Dastjerdi P, Abdollahi M, Yazdanpanah H, Barahimi M, Mirzaei A, Moshfeghinia R, Ranjbar M, Azami P, Abdollahi A, Bakhshi H, Attar A.   +12 more
europepmc   +1 more source

Endovascular treatment of posterior circulation aneurysms with flow diverters with hydrophilic polymer coating in patients receiving prasugrel single antiplatelet therapy: a multicenter case series presenting complication and occlusion rates. [PDF]

J Neurointerv Surg
Khanafer A, Sirakov A, Lobsien D, Cohen JE, Almohammad M, Schüngel MS, Hennersdorf F, Borgmann T, Ali Z, Filioglo A, Bäzner H, von Gottberg P, Hajiyev K, Albiña-Palmarola P, Felber S, Forsting M, Schob S, Kemmling A, Klisch J, Sirakov S, Henkes H.   +20 more
europepmc   +1 more source

P2Y₁₂ Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS Study. [PDF]

J Atheroscler Thromb
Fujimoto S, Iguchi Y, Yamagami H, Koga M, Itabashi R, Yakushiji Y, Kowata K, Kimura N, Terasawa Y, Shimizu T, Miyazaki Y, Oki K, Masuo O, Matsuoka H, Arakawa S, Ueda T, Tanaka R, Hashimoto W, Abe S, Kato G, Furugori T, Kimura K, ACUTE-PRAS Investigators.   +22 more
europepmc   +1 more source

Comparing anti-platelet and anti-thrombin therapies in the ischaemia-reperfusion injured coronary microcirculation of healthy and diabetic mice. [PDF]

Basic Res Cardiol
Mitchell JL, El-Awaisi J, Kavanagh D, Nieswandt B, Storey RF, Kalia N.   +5 more
europepmc   +1 more source